Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
12/2003
12/24/2003WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
12/24/2003WO2001085193A8 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
12/24/2003CA2489179A1 Method of treating ischemia reperfusion injury using adenosine receptor antagonists
12/18/2003WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003WO2003103640A1 Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
12/18/2003WO2003103575A2 Compounds, compositions, and methods
12/18/2003WO2003103475A2 Prevention and reduction of blood loss
12/18/2003WO2002017878A8 Lung surfactant compositions with dynamic swelling behaviour
12/18/2003CA2488558A1 Prevention and reduction of blood loss
12/18/2003CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/16/2003US6663878 Anti-inflammatory bioactive glass particulates
12/11/2003WO2003101424A1 Modified release pharmaceutical formulation
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/10/2003EP1368419A2 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
12/10/2003EP1368309A2 Thiol-modified hyaluronan
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003US20030225152 Such as 3-phenylaminomethylene-1,3-dihydroindol-2-one; use treating cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases
12/04/2003CA2484822A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/03/2003EP1365769A1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656960 Administering drug to produce cardiac asystole upon stimulation of one or both vagus nerves; inserting an electrode into esophagus of patient; actuating electrode to create an electrical field effective to stimulate vagus nerve
11/2003
11/27/2003WO2003097066A1 Use of meloxicam for alleviating organ injury during organ operation or transplantation
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003US20030220389 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219496 Methods of treating vascular disease
11/27/2003CA2486141A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/26/2003EP1363993A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK)
11/26/2003EP1363657A2 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
11/20/2003WO2003055531A3 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216393 Administering to a patient in need an effective pain treating amount of a substituted 1-aminobutan-3-ol compound to treat migraines, hyperalgesia, inflammatory pain, and post-operative pain
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003CN1127956C Medicine for curing and operating purpose and its preparing method
11/13/2003WO2003093313A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003WO2003093260A1 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
11/13/2003WO2003092707A1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003US20030212066 1-Sulfonyl pyrrolidine derivatives
11/13/2003US20030212024 Compositions and methods for cell dedifferentiation and tissue regeneration
11/13/2003US20030211993 Control cell proliferation, cell differentiation; culture product
11/13/2003CA2484155A1 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003CA2483532A1 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
11/12/2003EP1359947A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1454667A Convenient fibrin blocking agent
11/12/2003CN1454613A Use of root of red-rooted salvia, pseudo-ginseng and borneol for preparing medicine for reducing after-care restricture of PCI
11/11/2003US6645936 Administering ophthalmic lactoferrin solution to eyes of patient after sclerocorneal incision as wound healing agent
11/11/2003US6645521 Local prevention or amelioration of pain from surgically closed wounds
11/06/2003WO2003091283A1 Gelatin derivatives and high-molecular micelles comprising the same
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091232A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003WO2003090748A1 Use of compounds having ccr antagonism
11/06/2003WO2003007686A3 Use of copper chelators to inhibit the inactivation of protein c
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003CA2483253A1 Use of compounds having ccr antagonism
11/06/2003CA2483155A1 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/05/2003CN1454087A The use of scopolamine salts
11/04/2003US6641571 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002032447A3 Cell damage inhibitor
10/29/2003EP1251853B1 Transdermal therapeutic system for the administration of zaleplon
10/29/2003EP1202754B1 Use of fibrinogen multimers in fibrin sealants
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/22/2003EP1354868A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof
10/22/2003EP1354582A2 Emulsion preconcentrates containing cyclosporin or a macrolide
10/22/2003EP1353692A2 Methods and compositions for treatment of ocular neovascularization and neural injury
10/22/2003EP1194441B1 A2a receptor agonists
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003US20030194415 Film-forming compositions and methods
10/16/2003CA2481879A1 Hydroxamic acid derivatives
10/15/2003CN1449278A Lung surfactant compositions with dynamic swelling behaviour
10/14/2003US6632423 To prevent or reduce fibrosis and/or adhesion in traumatized tissues, comprising the administration of a stabilizing effective amount of the agent to the traumatized tissue
10/09/2003WO2003083091A1 Dedifferentiated, programmable stem cells having a monocytic origin and the production and use thereof
10/09/2003WO2003082245A1 Methods of using lamellar bodies for therapeutic purposes
10/09/2003WO2002074056A3 Allosteric adenosine receptor modulators
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders
10/08/2003CN1447799A Giphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1446544A Anti blocking new mateial used after surgical operation
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1347754A2 Compositions for adhesion prevention
10/01/2003EP1014998B1 Polymeric compositions
10/01/2003CN1446230A Peptide and peptide mimetic derivatives with integrin inhibitor preperties Ôàí"
10/01/2003CN1446101A Combination product comprising melagatran and factor VLLa inhibitor
09/2003
09/25/2003WO2003078413A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
09/25/2003US20030181477 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/25/2003US20030181476 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/25/2003US20030181469 Crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 38